Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Ellen M. Zane
AddedMar 31, 2024
UpdatedMay 1, 2026
Ellen M. Zane

Ellen M. Zane

Board Member, Azenta

Ellen M. Zane's Career

Azenta
Azenta

Burlington, MA, US

Board Member· Board
Haemonetics
Haemonetics

Boston, MA, US

Board Member· Board
Fiduciary Trust Company
Fiduciary Trust Company

Boston, MA, US

Board Member· Board
AgNovos Healthcare
AgNovos Healthcare

Rockville, MD, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Ellen M. Zane's Career

Azenta
Azenta
Public$508.3M3.2k1994Burlington, MA, US
Board Member· Board

Leadership at Azenta

Stephen S. SchwartzStephen S. SchwartzCEO
Mark S. WrightonMark S. WrightonBoard Member
Joseph MartinJoseph MartinBoard Member
Rolf EhrhardtRolf EhrhardtCo-Founder
Steve SchwartzSteve SchwartzBoard Member
Michael RosenblattMichael RosenblattBoard Member

Similar to Azenta

Enzo BiochemEnzo BiochemNew York City, NY, USDiagnostic Services, Healthcare Productsest. 1976Enzo BiochemNew York City, NY, US · est. 1976

Enzo Biochem, a NY-based company, develops healthcare products and provides diagnostic services globally using advanced genetic techniques.

Public190
Thermo Fisher thThermo Fisher thWaltham, MA, USLaboratory Products, Scientific Instrumentsest. 2006Thermo Fisher thWaltham, MA, US · est. 2006

Global provider of scientific instruments & consumables.

Public · $119B130k
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
RevvityRevvityWaltham, MA, USBiotech, Health Scienceest. 2023RevvityWaltham, MA, US · est. 2023

Revvity, Inc.: A global biotech firm providing health science solutions and multi-omics technologies.

Public16.7k
Haemonetics
Haemonetics
Public$1.1B3.3k1971Boston, MA, US
Board Member· Board

Leadership at Haemonetics

Christopher SimonChristopher SimonCEO
Michael J. CoyleMichael J. CoyleBoard Member
Richard J. MeeliaRichard J. MeeliaBoard Member
Chris SimonChris SimonBoard Member
Jack LathamJack LathamFounder
Fiduciary Trust Company
Fiduciary Trust Company
Investment FirmInvestment Firm$6M1961885Boston, MA, US
Board Member· Board

Leadership at Fiduciary Trust Company

Austin V. ShapardAustin V. ShapardCEO
Brent L HenryBrent L HenryBoard Member
AgNovos Healthcare
AgNovos Healthcare
Series C$31.5M572012Rockville, MD, US
Board Member· Board

Leadership at AgNovos Healthcare

Scott FloraScott FloraBoard Member
James HoweJames HoweFounder
Nick ValerianiNick ValerianiBoard Member
Tanner HoweTanner HoweCEO
Dawn SvoronosDawn SvoronosBoard Member

Ellen M. Zane's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Ellen M. Zane

Michael DandorphMichael DandorphBoard Member · American Heart AssociationBarbara HillBarbara HillBoard Member · Omega Healthcare InvestorsMark LaretMark LaretBoard Member · RegardAnne KlibanskiAnne KlibanskiBoard Member · Mass General BrighamKurt NewmanKurt NewmanBoard Member · BioHealth InnovationDoug WilliamsDoug WilliamsCEO · Harvard Medical School